Connect your AI

QuidelOrtho Corporation QDEL Price / sales

Price / sales at other companies

AbbottABT

4×-1.5×

Bio-Rad LaboratoriesBIO

2.9×+0.2×

DanaherDHR

5.4×-0.7×

RevvityRVTY

3.4×-1.2×

Quest DiagnosticsDGX

1.9×+0.1×

Opko HealthOPK

1.5×-0.1×

Other financials

Income statement

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

Market cap$832.61M-56.1%

Enterprise value$3.8B-22.0%

Profitability

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

market cap/total revenue=0.3×

Based on the most recent quarter.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is QuidelOrtho Corporation's price / sales?: QuidelOrtho Corporation (QDEL) reported price / sales of 0.3× in Q1 2026.
How has QuidelOrtho Corporation's price / sales changed year-over-year?: QuidelOrtho Corporation's price / sales decreased by 53.5% year-over-year, from 0.7× to 0.3×.
What is the long-term trend for QuidelOrtho Corporation's price / sales?: Over 5 years (2020 to 2025), QuidelOrtho Corporation's price / sales has grown at a -36.0% compound annual growth rate (CAGR), from 6.3× to 0.7×.
What does price / sales mean?: Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.